Joshua Wolf, PhD, MBBS
Joshua Wolf, PhD, MBBS

Joshua Wolf, PhD, MBBS

Associate Member, St. Jude Faculty



BA – University of Melbourne
MBBS – University of Melbourne
PhD - Unversity of Melbourne

Research Interests

  • Prediction, Prevention and Treatment of Infections in Immunocompromised Children
  • Management of Device-Associated Infections

Selected Publications

Wolf J, Connell T, Allison K, Tang L, Richardson J, Branum K, Borello E, Rubnitz J, Gaur AH, Hakim H, Su Y, Federico S, Mechinaud F, Hayden RT, Monagle P, Worth L, Curtis N, Flynn PM. Ethanol lock treatment and secondary prophylaxis for central line-associated bloodstream infection in pediatric hematology/oncology: a randomized, double-blind, placebo-controlled, intervention trial. The Lancet Infectious Diseases ePub ahead of print, 2018.

Hakim H, Dallas R, Wolf J, Tang L, Schultz-Cherry S, Darling V, Johnson C, Karlsson E, Chang T-C, Jeha S, Pui C-H, Sun Y, Pounds S, Hayden RT, Tuomanen EI, Rosch JW. Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia. Clinical Infectious Diseases ePub ahead of print, 2018.

Sun Y, Huskey R, Tang L, Inaba H, Rubnitz J, Wolf J. Adverse effects of intravenous vancomycin-based prophylaxis during therapy for pediatric acute myeloid leukemia, Antimicrobial Agents and Chemotherapy 62:e01838-17, 2018.

Wolf J, Tang L, Flynn PM, Pui C-H, Gaur AH, Sun Y, Inaba H, Stewart T, Hayden RT, Hakim H, Jeha S. Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia. Clinical Infectious Diseases 65:1798-8, 2017.

Honsa ES, Cooper VS, Mhaissen MN, Frank M, Shaker J, Iverson A, Rubnitz J, Hayden RT, Lee RE, Rock C, Tuomanen EI, Wolf J*, Rosch JW*. RelA mutant Enterococcus faecium with multi-antibiotic tolerance arising in an immunocompromised host. mBio 8:e02124-16, 2017. *Co-corresponding authors.

Inaba H, Pei D, Wolf J, Hayden RT, Go M, Varechtchouk O, Hahn T, Buaboonnam J,. Metzger ML, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Cheng C, Evans WE, Relling MV, Pui CH, Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Annals of Oncology 28:386-392, 2017.

Shenep MA, Tanner MR, Sun Y, Culley T, Hayden RT, Flynn PM, Tang L, Wolf J. Catheter-related complications in children with cancer who receive parenteral nutrition: Change in risk is moderated by catheter type. Journal of Parenteral and Enteral Nutrition 41:1063-107, 2017.

Ferguson-Paul K, Mangum S, Porter A, Leventaki V, Campbell P, Wolf J. Hemophagocytic lymphohistiocytosis and progressive disseminated histoplasmosis. Emerging Infectious Diseases 22:1119-1121, 2016

Wolf J, Tang L, Rubnitz JE, Brennan RC, Shook DR, Stokes DC, Monagle P, Curtis N, Worth LJ, Allison KJ, Sun Y, Flynn PM. Monitoring central venous catheter resistance to predict imminent occlusion: A prospective pilot study. PLOS ONE 10:e0135904, 2015.

Wolf J. Antibiotic resistance threatens the efficacy of prophylaxis. The Lancet Infectious Diseases 15:1368-1369, 2015.

Wolf J, Sun Y, Tang L, Newland JG, Gerber JS, Van Dyke CJ, Hymes SR, Yu D, Carias DC, Bryant PA. Antimicrobial stewardship barriers and goals in pediatric oncology and bone marrow transplantation: A survey of antimicrobial stewardship practitioners. Infection Control and Hospital Epidemiology 37:343-347, 2015.

Wolf J, Allison KJ, Tang L, Sun Y, Hayden RT, Flynn PM. No evidence of benefit from antibiotic lock therapy in pediatric oncology patients with central line-related bloodstream infection: Results of a retrospective matched cohort study and review of the literature. Pediatric Blood and Cancer 61:1811-1815, 2014.

Carter R*, Wolf J*, van Opijnen T*, Muller M, Obert C, Burnham C, Mann B, Li Y, Hayden RT, Pestina T, Persons D, Camilli A, Flynn PM, Tuomanen EI, Rosch JW. Genomic analysis of pneumococci from children with sickle cell disease reveals disease-specific bacterial adaptations and deficits in current clinical interventions. Cell Host & Microbe 15:587-599, 2014. *Equal contribution.

Cooley L, Dendle C, Wolf J, Teh BW, Chen SC, Boutlis C, Thursky KA. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies. Internal Medicine Journal 44:1350-1363, 2014.

Wolf J, Curtis N. Wash your hands after playing with that dragon! Journal of Paediatrics and Child Health 50:1023-1024, 2014.

Wolf J, Curtis N, Worth LJ, Flynn PM. Central line-associated bloodstream infection in children: an update on treatment. Pediatric Infectious Diseases Journal 32:905-910, 2013.

Wolf J, Shenep JL, Clifford V, Curtis N, Flynn PM. Ethanol lock therapy in Pediatric Hematology and Oncology. Pediatric Blood and Cancer 60:18-25, 2013.

Wolf J, Daley AJ, Tilse MH, Nimmo GR, Bell S, Howell AJ, Keil AD, Lawrence A, Curtis N. Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian Children. Journal of Paediatrics and Child Health 46:404-11, 2010.

Wolf J, South M. Image of the month: A swollen eye. Journal of Paediatrics and Child Health 46:203, 2010.

Wolf J, Slavin MA. Risk-based antifungal prophylaxis in patients with haematological malignancies.Current Reports in Infectious Diseases 11:420-6, 2009.

Nairn EK, Wolf J, Buttery JP. The hidden cost of varicella. Medical Journal of Australia 190:4, 2009.

Wolf J, Curtis N. Brain abscess secondary to dental braces. Pediatric Infectious Disease Journal 27:84, 2008.

Wolf J, Salo R. Water, water, everywhere, Nor any drop to drink: climate change delusion. Australian and New Zealand Journal of Psychiatry 42:350, 2008.

Wolf J, Daley A J. Microbiological aspects of bacterial lower respiratory tract illness in children: Atypical pathogens. Paediatric Respiratory Reviews 8:204-211, 2007.

Wolf J, Daley A J. Microbiological aspects of bacterial lower respiratory tract illness in children: Typical pathogens. Paediatric Respiratory Reviews 8:212-220, 2007.

Johnson DF, Druce JD, Chapman S, Swaminathan A, Wolf J, Richards JS, Korman T, Birch C, Richards MJ. Chikungunya virus infection in travellers to Australia. Medical Journal of Australia 188:41-43, 2008.

Wolf J, Curtis N, Buttery J et al. Liposomal amphotericin trial marred by conclusion. Clinical Infectious Diseases 45:667-668, 2007.

Bartlett J, Lee S, Mishina Y, Behringer R, Yang N, Wolf J, Temelcos C, Hutson J. Gubernacular development in Mullerian inhibiting substance receptor-deficient mice. BJU International 89(1), 2002.

Last update: June 2018

For updates on COVID-19, please read.